Nausea During Pregnancy and Timing of Pubertal Development in Sons and Daughters: A Population-Based Cohort Study

Mette Rahbek Bruun1, Andreas Ernst1,2, Linn Håkonsen Arendt1,3

  • 1Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark.

Clinical Epidemiology
|October 8, 2021
PubMed

Insights

Maternal nausea during pregnancy was not linked to the timing of puberty in children. This study found no association between pregnancy sickness and pubertal milestones in sons and daughters.

Area of Science:

  • Reproductive Endocrinology
  • Pediatric Development
  • Human Reproduction

Background:

  • Maternal nausea during pregnancy may indicate endogenous estrogen levels.
  • Estrogen plays a crucial role in pubertal development.
  • The relationship between pregnancy sickness and pubertal timing requires further investigation.

Purpose of the Study:

  • To investigate the association between maternal nausea during pregnancy and the age of pubertal milestone attainment in offspring.
  • To determine if nausea, as a potential marker of estrogen exposure, influences pubertal timing in both boys and girls.

Main Methods:

  • A cohort of 14,612 children from the Danish National Birth Cohort (born 2000-2003) was studied.
  • Mothers reported nausea during pregnancy via telephone interviews.
  • Children's pubertal status was assessed from age 11 to 18, tracking milestones like pubic hair development, menarche, and voice changes.

Main Results:

  • No significant association was found between the duration or severity of maternal nausea in the first trimester and pubertal timing.
  • Extended nausea duration across the first two trimesters also showed no link to pubertal development.
  • Neither nausea duration nor its severity correlated with the age of attaining pubertal milestones.

Conclusions:

  • The study does not support the hypothesis that maternal nausea during pregnancy is a predictor of pubertal timing in children.
  • Pregnancy sickness, as a surrogate for estrogen levels, does not appear to influence the age of pubertal development.
  • Further research may be needed to explore other factors influencing pubertal timing.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
259
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
294
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.4K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
743